NGUYENTHAO NGUYEN, MSN, APRN, FNP-BC
Nurse Practitioner · FREMONT, CA
Individual Active NPI 1285320259
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 170 | 150,371 | $7,875,458 | $2,571,472 | $2,044,648 |
| 2023 | 140 | 43,948 | $3,098,663 | $1,055,295 | $840,812 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | 77,640 | $6 | $5 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 13,300 | $11 | $9 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,675 | $43 | $34 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,650 | $31 | $25 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 432 | $0 | $0 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 298 | $150 | $119 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 215 | $72 | $57 |
| 96372 | Injection of drug or substance under skin or into muscle | 169 | $15 | $12 |
| 96415 | Administration of chemotherapy into vein, each additional hour | 85 | $30 | $24 |
| 96375 | Injection of additional new drug or substance into vein | 33 | $17 | $14 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Nurse Practitioner | 363L00000X | ✓ | 95021739 | CA |
| Registered Nurse | 163W00000X | 95146626 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Nurse Practitioner providers in California
- NPI 1285062257
- NPI 1386705853
- NPI 1457839581
- NPI 1952780652
- NPI 1710808191
- NPI 1679464440
- NPI 1194761296
- NPI 1497429302
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.